Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
McKesson
Mallinckrodt
Harvard Business School
McKinsey

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Troxacitabine

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug Troxacitabine?

Troxacitabine is an investigational drug.

There have been 4 clinical trials for Troxacitabine. The most recent clinical trial was a Phase 2 trial, which was initiated on July 1st 2005.

The most common disease conditions in clinical trials are Leukemia, Myeloid, Leukemia, and Leukemia, Myeloid, Acute. The leading clinical trial sponsors are SGX Pharmaceuticals, Inc., Shire, and [disabled in preview].

Recent Clinical Trials for Troxacitabine
TitleSponsorPhase
Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)SGX Pharmaceuticals, Inc.Phase 2
Study of Troxatylâ„¢ Administered by Continuous Infusion to Subjects With Refractory Acute Myelogenous Leukemia (AML)SGX Pharmaceuticals, Inc.Phase 1/Phase 2
Study of Troxatylâ„¢ Administered by Continuous Infusion to Subjects With Solid TumorsSGX Pharmaceuticals, Inc.Phase 1/Phase 2

See all Troxacitabine clinical trials

Clinical Trial Summary for Troxacitabine

Top disease conditions for Troxacitabine
Top clinical trial sponsors for Troxacitabine

See all Troxacitabine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Dow
Express Scripts
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.